Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 3Phase 1/2 1

Status

Completed 3

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3Other hematologic neoplasm 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1Breast 1

Conditions

Carcinoma, Renal Cell 10Neoplasms 8Neoplasm Metastasis 8Endometrial Neoplasms 6Breast Neoplasms 6Brain Neoplasms 5Unspecified Adult Solid Tumor, Protocol Specific 4Prostatic Neoplasms 4Melanoma 4Lymphoma 4Kidney Neoplasms 4Glioblastoma 4Advanced Cancer 4Uterine Cervical Neoplasms 3Sarcoma 3Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Multiple Myeloma 3Glioma 3Central Nervous System Neoplasms 3Unspecified Childhood Solid Tumor, Protocol Specific 2Solid Tumors 2Small Cell Lung Carcinoma 2Resistant Solid Malignancies 2Pinealoma 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Oligodendroglioma 2Lymphoma, Mantle-Cell 2Lung Neoplasms 2

Interventions

Dexamethasone 129Lenalidomide 70Cyclophosphamide 70Bortezomib 69Calcium Dobesilate 50fludarabine 44pomalidomide 40daratumumab 37carfilzomib 33fludarabine phosphate 31Melphalan 25dexamethasone acetate 20dexamethasone 21-phosphate 20auricularum 18Filgrastim 18Whole-Body Irradiation 14Biopsy 13isatuximab 12Vorinostat 12Tacrolimus 12Peripheral Blood Stem Cell Transplantation 12Magnetic Resonance Spectroscopy 12Granulocyte Colony-Stimulating Factor 12Specimen Handling 11Sirolimus 11ixazomib 10belantamab mafodotin 10Panobinostat 10Mycophenolic Acid 10Cyclosporine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Multiple Myeloma × temsirolimus × Clear all
NCT01183663 2016-06-03

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

M.D. Anderson Cancer Center

Phase 1 Completed
180 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryOther hematologic neoplasmPlasma cell

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Glioblastoma, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT00693433 2015-12-04

Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma

National Cancer Institute (NCI)

Phase 1 Completed
15 enrolled
Plasma cell

Multiple Myeloma

NCT00398515 2013-09-30

Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma

National Cancer Institute (NCI)

Phase 1 Completed
25 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡